The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases

Neurodegenerative diseases (NDs) belong to the top global causes of mortality. Diagnostic approaches to improve early diagnosis and differentiation of these diseases are constantly being sought. Therefore, we aimed to assess the cerebrospinal fluid (CSF) concentrations of Reticulon 4 (RTN4) in patie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Agnieszka Kulczyńska-Przybik, Maciej Dulewicz, Agnieszka Słowik, Renata Borawska, Alina Kułakowska, Jan Kochanowicz, Barbara Mroczko
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/d52f043bcdfc40b9ac39ec16e5b669b8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d52f043bcdfc40b9ac39ec16e5b669b8
record_format dspace
spelling oai:doaj.org-article:d52f043bcdfc40b9ac39ec16e5b669b82021-11-25T18:01:20ZThe Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases10.3390/jcm102252812077-0383https://doaj.org/article/d52f043bcdfc40b9ac39ec16e5b669b82021-11-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/22/5281https://doaj.org/toc/2077-0383Neurodegenerative diseases (NDs) belong to the top global causes of mortality. Diagnostic approaches to improve early diagnosis and differentiation of these diseases are constantly being sought. Therefore, we aimed to assess the cerebrospinal fluid (CSF) concentrations of Reticulon 4 (RTN4) in patients with neurodegenerative diseases and evaluate the potential clinical usefulness of this protein. RTNs are transmembrane proteins mediating neuroanatomical plasticity and functional recovery after central nervous system injury or diseases. According to our best knowledge, this is the first investigation providing the data concerning the dynamic of CSF RTN4 protein levels in patients with different NDs. Methods: Overall, 77 newly diagnosed patients with neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and multiple sclerosis (MS), as well as 21 controls, were enrolled in the study. The CSF concentrations of tested proteins were assessed using immunological assays. Results: We revealed significantly higher CSF RTN4A levels in patients with AD, PD, and MS in comparison to the controls. Moreover, the comparative analysis of RTN4 concentration between different neurodegenerative diseases revealed the highest concentration of RTN4A in AD patients and a statistically significant difference between AD vs. PD, and AD vs. MS groups. The increased CSF level of the protein correlated with Tau, and pTau181 proteins in AD as well as in PD patients. Conclusions: Our study presents a previously not identified clinical utility of RTN4 in the differential diagnosis of neurodegenerative diseases.Agnieszka Kulczyńska-PrzybikMaciej DulewiczAgnieszka SłowikRenata BorawskaAlina KułakowskaJan KochanowiczBarbara MroczkoMDPI AGarticleRTN-4AreticulonsbiomarkersAlzheimer’s diseaseParkinson’s diseasemultiple sclerosisMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5281, p 5281 (2021)
institution DOAJ
collection DOAJ
language EN
topic RTN-4A
reticulons
biomarkers
Alzheimer’s disease
Parkinson’s disease
multiple sclerosis
Medicine
R
spellingShingle RTN-4A
reticulons
biomarkers
Alzheimer’s disease
Parkinson’s disease
multiple sclerosis
Medicine
R
Agnieszka Kulczyńska-Przybik
Maciej Dulewicz
Agnieszka Słowik
Renata Borawska
Alina Kułakowska
Jan Kochanowicz
Barbara Mroczko
The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
description Neurodegenerative diseases (NDs) belong to the top global causes of mortality. Diagnostic approaches to improve early diagnosis and differentiation of these diseases are constantly being sought. Therefore, we aimed to assess the cerebrospinal fluid (CSF) concentrations of Reticulon 4 (RTN4) in patients with neurodegenerative diseases and evaluate the potential clinical usefulness of this protein. RTNs are transmembrane proteins mediating neuroanatomical plasticity and functional recovery after central nervous system injury or diseases. According to our best knowledge, this is the first investigation providing the data concerning the dynamic of CSF RTN4 protein levels in patients with different NDs. Methods: Overall, 77 newly diagnosed patients with neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and multiple sclerosis (MS), as well as 21 controls, were enrolled in the study. The CSF concentrations of tested proteins were assessed using immunological assays. Results: We revealed significantly higher CSF RTN4A levels in patients with AD, PD, and MS in comparison to the controls. Moreover, the comparative analysis of RTN4 concentration between different neurodegenerative diseases revealed the highest concentration of RTN4A in AD patients and a statistically significant difference between AD vs. PD, and AD vs. MS groups. The increased CSF level of the protein correlated with Tau, and pTau181 proteins in AD as well as in PD patients. Conclusions: Our study presents a previously not identified clinical utility of RTN4 in the differential diagnosis of neurodegenerative diseases.
format article
author Agnieszka Kulczyńska-Przybik
Maciej Dulewicz
Agnieszka Słowik
Renata Borawska
Alina Kułakowska
Jan Kochanowicz
Barbara Mroczko
author_facet Agnieszka Kulczyńska-Przybik
Maciej Dulewicz
Agnieszka Słowik
Renata Borawska
Alina Kułakowska
Jan Kochanowicz
Barbara Mroczko
author_sort Agnieszka Kulczyńska-Przybik
title The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
title_short The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
title_full The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
title_fullStr The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
title_full_unstemmed The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
title_sort clinical significance of cerebrospinal fluid reticulon 4 (rtn4) levels in the differential diagnosis of neurodegenerative diseases
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d52f043bcdfc40b9ac39ec16e5b669b8
work_keys_str_mv AT agnieszkakulczynskaprzybik theclinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT maciejdulewicz theclinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT agnieszkasłowik theclinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT renataborawska theclinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT alinakułakowska theclinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT jankochanowicz theclinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT barbaramroczko theclinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT agnieszkakulczynskaprzybik clinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT maciejdulewicz clinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT agnieszkasłowik clinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT renataborawska clinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT alinakułakowska clinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT jankochanowicz clinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
AT barbaramroczko clinicalsignificanceofcerebrospinalfluidreticulon4rtn4levelsinthedifferentialdiagnosisofneurodegenerativediseases
_version_ 1718411771032633344